中文 | English
Return
Total: 7373 , 1/738
Show Home Prev Next End page: GO
Author:(YANG XIN)

1.Risk factors and management of diabetes-related macular hard exudates

Xin, YANG

Chinese Journal of Experimental Ophthalmology 2013;32(11):1041-1046

2.Research progress on biomarkers for early diagnosis of sepsis

Xin YANG

International Journal of Pediatrics 2017;44(8):531-534

3.Advances in the research of staphylococcus aureus accessory gene regulator system dysfunction

Xin YANG

International Journal of Pediatrics 2017;44(2):94-98

4.Research progress of defibrotide in the treatment and prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation

Xin YANG ; Sizhou FENG

Journal of Leukemia & Lymphoma 2013;22(7):389-392

5.Investigation and analysis of the information ability of medical personnel under the network environment

Xin XU ; Hua YANG

Chinese Journal of Medical Education Research 2015;14(6):643-648

6.The superposition effect of moxibustion and ear acupoint pressing method in Sodium Hyaluronate Eye Drops treatment of dry eye

Xin MAO ; Aiying YANG

International Journal of Traditional Chinese Medicine 2015;37(9):792-795

7.Correlation between expression of Ki-67, PCNA and sensitivity of adjuvant chemotherapy in breast cancer patients

Xin WEI ; Julun YANG

Chinese Journal of Immunology 2014;(11):1549-1551

8.Relationship between ERCC1,Ki67,PCNA expression with anthracycline chemo-therapeutic drugs′sensitivity in breast cancer tissues

Xin WEI ; Julun YANG

Chinese Journal of Immunology 2015;(2):169-172

9.Clinical and experimental research on Cuochuang Misture for treatment of acne vulgaris of syndrome of dampness and heat in lung and stomach

Lan YANG ; Xin QU

China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(03):-

10.Retrospective Analysis of 756 Cases of Clinical Drug Consultation

Shugui YANG ; Xin ZHANG

Chinese Journal of Pharmacoepidemiology 2007;0(05):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7373 , 1/738 Show Home Prev Next End page: GO